The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Person who experienced the adverse event (patient)

Event ID CASEID CASEVERSION I F COD EVENT DT MFR DT INIT FDA DT FDA DT REPT COD AUTH NUM MFR NUM MFR SNDR LIT REF AGE AGE COD AGE GRP GNDR COD E SUB WT WT COD REPT DT TO MFR OCCP COD REPORTER COUNTRY OCCR COUNTRY
127116551 12711655 1 I 20160824 20160902 20160902 EXP JP-BAYER-2016-167405 BAYER ARIYAMA Y, SAITO M, HIDAKA S, KANAZAWA S, NAGAOKA S, BABA S, ET. AL. A CASE OF ALVEOLAR HEMORRHAGE DURING ANTICOAGULANT/ANTIPLATELET THERAPY FOR STROKE IN PREGNANCY. TOKYO JOURNAL OF OBSTETRICS AND GYNECOLOGY. 2016;65(3):473-477 34.00 YR A F Y 44.40000 KG 20160902 MD JP JP

Drug(s) used by person

Event ID CASEID DRUG SEQ ROLE COD DRUGNAME PROD AI VAL VBM ROUTE DOSE VBM CUM DOSE CHR CUM DOSE UNIT DECHAL RECHAL LOT NUM EXP DT NDA NUM DOSE AMT DOSE UNIT DOSE FORM DOSE FREQ
127116551 12711655 1 PS ACETYLSALICYLIC ACID({=100 mg) ASPIRIN 1 Oral 100 MG, QD Y 21317 100 MG TABLET QD
127116551 12711655 2 SS ACETYLSALICYLIC ACID({=100 mg) ASPIRIN 1 Y 21317 TABLET
127116551 12711655 3 SS CLOPIDOGREL CLOPIDOGREL BISULFATE 1 Oral 75 MG, QD 0 75 MG QD
127116551 12711655 4 SS CLOPIDOGREL CLOPIDOGREL BISULFATE 1 0
127116551 12711655 5 SS HEPARIN HEPARIN SODIUM 1 10000 U, QD 0 10000 IU QD
127116551 12711655 6 SS HEPARIN HEPARIN SODIUM 1 0
127116551 12711655 7 SS MAGNESIUM SULFATE. MAGNESIUM SULFATE 1 0
127116551 12711655 8 SS RITODRINE RITODRINE 1 0
127116551 12711655 9 SS RITODRINE RITODRINE 1 INCREASED DOSE 0
127116551 12711655 10 SS RITODRINE RITODRINE 1 133 ?G/MIN 0
127116551 12711655 11 SS RITODRINE RITODRINE 1 83 ?G/MIN AND MG 1.6 G/H. 0
127116551 12711655 12 C PLATELETS HUMAN PLATELET, ALLOGENIC 1 DAILY DOSE 10 DF 0 10 DF
127116551 12711655 13 C RED CELLS MAP HUMAN RED BLOOD CELL 1 DAILY DOSE 4 DF 0 4 DF
127116551 12711655 14 C CILOSTAZOL. CILOSTAZOL 1 200 MG, QD 0 200 MG QD

Indications of drugs used

Event ID CASEID INDI DRUG SEQ INDI PT
127116551 12711655 1 Cerebellar infarction
127116551 12711655 2 Cerebellar infarction
127116551 12711655 3 Basilar artery stenosis
127116551 12711655 4 Brain stem infarction
127116551 12711655 5 Basilar artery stenosis
127116551 12711655 6 Brain stem infarction
127116551 12711655 7 Threatened labour
127116551 12711655 8 Threatened labour
127116551 12711655 9 Threatened labour
127116551 12711655 10 Threatened labour
127116551 12711655 11 Threatened labour

Outcome of event

Event ID CASEID OUTC COD
127116551 12711655 OT
127116551 12711655 HO

Reactions reported

Event ID CASEID DRUG REC ACT PT
127116551 12711655 Basilar artery stenosis
127116551 12711655 Brain stem infarction
127116551 12711655 Contraindicated product administered
127116551 12711655 Drug administration error
127116551 12711655 Labelled drug-drug interaction medication error
127116551 12711655 Maternal exposure during pregnancy
127116551 12711655 Premature delivery
127116551 12711655 Pulmonary alveolar haemorrhage
127116551 12711655 Stevens-Johnson syndrome
127116551 12711655 Threatened labour

Reporting Sources (this data is often not reported and may therefore be missing here)

no results found

Therapies reported

no results found